QUALCOMM, Inc.: Financial Analysis

I like to keep my viewers updated with the latest news on stocks that I considered undervalued or worthy to be watched! You can check out all of my recent buys/sells and stock considerations at my site which can be found in my profile.

I like to use the CCC spreadsheet which is run and maintained by Dave Fish. When looking at the spreadsheet I like to add my own data filters. This helps me find companies that meet my set of criteria. After the filters were added, I now had a list of companies that I can start researching. This is how I came up with the three stocks listed today.

QUALCOMM, Inc. (QCOM)

Qualcomm is a semiconductor and telecommunications equipment company that primarily focuses on manufacturing components for mobile devices.

I am considering OHI as a buy because of the amazing dividend yield, and the fact that this company has been raising dividends for over 20 straight quarters.

OHI has a dividend yield of 8.24% with a 5-year dividend growth rate of 8.8%. This means that OHI has a Chowder Rule of 17.04. (Chowder Rule is when you add the current dividend with the 5-year dividend growth rate). Normally for REIT you would like a Chowder Rule of 8 or higher, but OHI is giving you 17.04 WOW!

The 5-year dividend yield average is 6.5%. So you can buy OHI over 174 basis points compared to the 5-year average.

Now "Can OHI continue to pay this dividend?"

The answer is yes, OHI can.

When analyzing REIT, you must look at Funds From Operation ((FFO)) instead of Earning Per Shares

is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health ((IH)) and Pfizer Essential Health ((EH)). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development ((R&D)) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra."

Source: Google.com

I am considering buying shares of PFE because I want to diversify and add more companies in the health sectors into my portfolio. I also find the company to be fair to undervalue right now.

Let's talk about the current dividend yield state. PFE dividend yield is at a nice level of 3.89%. The 5-year dividend yield average is 3.4%.

You do not get that big basis point jump like QCOM and OHI, but PFE yield is higher than the 5-year average as well as the broader market.

Back to the same question as the